Biological markers of serotonin receptors in depression and animal models of depression

References

• Aghajanian G.K., de Montigny C. Tricyclic antidepressants: Long term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978; 202: 1303–1306
   Google Scholar
• Agren H., Mefford I.N., Rudorfer M.V., et al. Interacting neurotransmitter systems. Journal of Psychiatric Research 1986; 20: 175–193
   PubMed Web of Science ®Google Scholar
• Arora R.C., Meltzer H.Y. Serotonin uptake by blood platelets by schizophrenic patients. Psychiatric Research 1982; 6: 327
   Google Scholar
• Arora R.C., Meltzer H.Y. Serotonergic measures in brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. American Journal of Psychiatry 1989; 146: 730–736
   PubMed Web of Science ®Google Scholar
• Arora R.C., Meltzer H.Y. Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims. Biological Psychiatry 1991; 29: 1016–1022
   Google Scholar
• Ayd F.J., Blackwell B. Discoveries in Biological Psychiatry. Lippincot, Philadelphia 1970
   Google Scholar
• Bayer S.M., McCoy E.E. A comparison of the 5-HT and ATP content in platelets from subjects with Down Syndrome. Biochemical Medicine 1974; 9: 225
   Google Scholar
• Bizot J.C., Thebot M.H., Puech A.J. Effects of 5-HT-related drugs on waiting behaviour in rats. Psychopharmacology 1988; 96: 55
   Google Scholar
• Blier P., Chaput Y., de Montigny C. Long term 5-HT reuptake blockade but not monoamine oxidase inhibition decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmieldeberg's Archives of Pharmacology 1988; 337: 246–254
   PubMed Web of Science ®Google Scholar
• Blier P., de Montigny C., Chaput Y. A role for die serotonin systems in the mechanism of action of antidepressants. Journal of Clinical Psychiatry 1990; 51(suppl. 4)14–20
   Google Scholar
• Bocknik S.E., Kulkarnia A.A. Effects of a decarboxylase inhibitor (R04–4602) on 5-HTP induced muricide blockade in rats. Neuropharmacology 1974; 13: 279–87
   Google Scholar
• Boullin D.J., O'Brien P.A.M. Characterization of receptor mediating 5-HT and catecholamine induced platelet aggregation by alpha and beta blockers, butyrophenones, 5-HT antagonists and chlorpromazine. British Journal of Pharmacology 1971; 62: 537
   Google Scholar
• Braddock L.E., Cowen P.J., Eliott J.M., Fraser S., Stamp K. Changes in the binding to platelets of 3H-imipramine and 3H-yohimbine in normal subjects taking amitriptyline. Neuropharmacology 1984; 23: 285
   PubMed Web of Science ®Google Scholar
• Briley M.S., Langer S.Z., Raisman R., Sechter D., Zarihan E. 3H-imipramine binding sites are decreased on platelets of untreated depressed patients. Science 1980; 303: 1209
   Google Scholar
• Broekkamp C.L., Garrigon D., Lloyd K.G. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats. Pharmacology Biochemistry of Behaviour 1980; 13: 643–649
   PubMed Web of Science ®Google Scholar
• Brunello N., Voltera A., Cagiano R., et al. Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine. Naunyn Schmiedeberg's Archives of Pharmacology 1985; 331: 20–22
   Google Scholar
• Brusov O.S., Beliaeve B.S., Katasonov A.B., Zlobina G.P., Factor M.I., Lideman R.R. Does platelet serotonin receptor supersensitivity accompany endogenous depression?. Biological Psychiatry 1989; 25: 375
   Google Scholar
• Burnstein K.L., Cidlowski J.A. Regulation of gene expression by glucocorticoids. Annual Review of Physiology 1989; 51: 683–699
   PubMed Web of Science ®Google Scholar
• Butler J., Tannian M., Leonard B.E. The chronic effects of desipramine and sertraline on platelet and synaptosomal 5-HT uptake in olfactory bulbectomized rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1988; 12: 585–594
   Google Scholar
• Cairncross K.D., Cox B., Forster C., Wren A.F. Olfactory projection system, drugs and behaviour a review. Psychoneuroendocrinology 1979; 4: 253–73
   PubMedGoogle Scholar
• Chaput Y., Blier P., de Montigny C. In vivo electrophysiological evidence for die regulatory role of autoreceptors on serotongeric terminals. Journal of Neuroscience 1986; 6: 2796–2801
   PubMed Web of Science ®Google Scholar
• Charney D.S., Southwick S.M., Delgado P.L., . Current status of the receptor sensitivity hypothesis of antidepressant action. Pharmacotherapy of Depression, J.D. Amsterdam, et al. Marcel Dekker, New York, NY 1990
   Google Scholar
• Coppen A. The biochemistry of affective disorders. British Journal of Psychiatry 1967; 133: 1237–1264
   Google Scholar
• Coppen A., Swade C., Wood K. Platelet 5-hydroxytryptamine accumulation in depressive illness. Clinica Chimica Acta 1978; 87: 165
   PubMed Web of Science ®Google Scholar
• Davis A. Molecular aspects of the imipramine receptor. Experientia 1984; 40: 782
   Google Scholar
• Deakin J.F.W., Guimaraes F.S., Wang M., Hensman R. Experimental tests of the 5-HT receptor imbalance theory of affective disorders. 5-Hydroxytryptamine In Psychiatry, M. Sandler, A. Coppen, S. Harnetts. Oxford Medical Publications, Oxford 1991
   Google Scholar
• De Montigny C., Chaput Y., Buer P. Long term tricyclic and electroconvulsive treatment increases responsiveness of dorsal hippocampus 5-HTIA receptors: an electrophysiological study. Society of Neuroscience Abstracts 1989; 15: 854
   Google Scholar
• De Montigny C., Chaput Y., Buer P. Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. Journal of Clinical Psychiatry 1990; 51(Suppl. B)4–8
   Google Scholar
• De Montigny C., Chaput Y., Buer P. Classical and novel targets of antidepressant drugs. New Pharmacological Approaches to the Therapy of Depressive Disorders, J. Mendlewicz, N. Brunello, S.Z. Langer, G. Racagni. Karger, Basel 1993
   Google Scholar
• Dinan T.G. Glucocorticoids and the genesis of depressive illness. A psychobiological model. British Journal of Psychiatry 1994; 164: 365–371
   PubMed Web of Science ®Google Scholar
• Dray A., Gonge T.J., Oakley N.R. Evidence for the existence of a raphe projection to the substantia nigra in rat. Brain Research 1976; 113: 45–57
   PubMed Web of Science ®Google Scholar
• Earley B., Glennon M., Lally M., et al. Autoradiographic distribution of cholinergic muscarinic receptors in olfactory bulbectomized rat after chronic treatment with mianserin and desipramine. Proceedings of the Society for Neuroscience Abstracts No. 1. 1990
   Google Scholar
• Eisenstein N., Iorid L.C., Cody D.E. Role of serotonin in the blockade of muricidal behaviour by tricyclic antidepressants. Pharmacology Biochemistry and Behavior 1982; 17: 847–9
   Google Scholar
• Emrich H.M., Hollt V., Kissling W., et al. Beta endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders. Pharmacopsychiatry 1979; 2: 269–276
   Google Scholar
• Everett G.M., Toman T.E.O. Mode of action of Rauwolfia Serpentina alkloids and motor activity. Biological Psychiatry, J. Massermann. Grune and Stratton, New York 1959
   Google Scholar
• Finberg J.P.M., Tal A. Reduced peripheral pre-synaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats. British Journal of Pharmacology 1985; 84: 609
   Google Scholar
• Galzin A.M., Poirier M-F., Loo H., Sechter D., Zarifian E., Langer S.Z. 3H-paroxetine binding from healthy volunteers and depressed patients. British Journal of Pharmacology 1988; 93: 12
   Google Scholar
• Gay C., Langer S.Z., Loo H., Raisman R., Sechter D., Zarifan E. 3H-imipramine binding to platelets: A state dependent or independent biological markers. British Journal of Pharmacology 1983; 78: 57
   Google Scholar
• Gibbons J.L., Glusman M. Effects of quipazine, fluoxetine and fenfluramine on muricide in rats. Federation Proceedings of the Society for Experimentaql Biology 1978; 39: 257
   Google Scholar
• Giller G.L., Yehuda R., O'Loughun M. Lymphocyte glucocorticoid receptors in PTSD, major depression, panic and schizophrenia. Proceedings of the American College of Neuropsychopharmacology. 1988; 179
   Google Scholar
• Goodwin G.M., De Sousa R.J., Green A.R. Presynaptic serotonin receptor mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock. Nature 1985; 317: 531–533
   PubMedGoogle Scholar
• Gravel P., de Montigny C. Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment. Synapse 1987; 1: 233–239
   Google Scholar
• Hamon M., Emerit M.B., Mestikaws S., . Pharmacological, biochemical and functional properties of 5-HTIA binding sites labelled by 8-OH-DPAT in the rat brain. Brain 5-HT_IA receptors, C.T. Dourish, S. Ahlenius, P.H. Hudson, et al. Ellis Horwood, Chichester 1987
   Google Scholar
• Hannin I., Usdin E. Animal Models in Psychiatry and Neurology. Pergammon Press, Oxford 1977
   Google Scholar
• Harfstand A., Fuxe K., Cintra A. Glucocorticoid receptor immunoreactivity in monoamine neurons of rat brain. Proceedings of the National Academy of Science USA 1986; 83: 9779–9783
   Google Scholar
• Healy D., Carney P.A., Leonard B.E. Monoamine related markers of depression. Journal of Psychiatric Research 1983; 17: 251–258
   Web of Science ®Google Scholar
• Healy D., Carney P.A., O'Halloran A., Leonard B.E. Peripheral adrenoceptors and serotonin receptors in depression. Journal of Affective Disorders 1985; 17: 285–292
   Google Scholar
• Healy D., O'Halloran A., Carney P.A., Leonard B.E. Peripheral adrenoceptors and serotonin receptors in depression. Journal of Psychiatric Research 1985; 20: 345
   Google Scholar
• Hong K.W., Rion B.Y., Lee W.S. Enhancement of central and peripheral alpha T adrenoceptors sensitivity and reduction in alpha 2 adrenoceptor sensitivity following chronic imipramine treatment in rats. European Journal of Pharmacology 1986; 29: 275
   Google Scholar
• Hrdina P.D. Differences between sodium dependent and desipramine denned 3H-imipramine binding intact human platelets. Biological Psychiatry 1989; 25: 576
   Google Scholar
• Hyttel J. Pharmacological characterization of selective serotonin re-uptake inhibitors (SSRI's). International Journal of Psychopharmacology 1994; 9(Suppl. 1)19–26
   PubMedGoogle Scholar
• Johnson A.M. The comparative pharmacological properties of selective serotonin re-uptake inhibition in animals. Perspectives in Psychiatry, J.P. Feighner, W.F. Boyer. John Wiley, & Sons, Chichester 1991; vol. 1: 37–70
   Google Scholar
• Kendall D.A., Nahorski S.R. 5-Hydroxy-tryptamine stimulates inositol phospholipid hydrolysis in rat cerebral cortex slices: Pharmacological characterization and effects of antidepressants. Journal of Pharmacology and Experimental Therapeutics 1985; 23: 473–484
   Google Scholar
• Kitayama I., Cintra A.M., Fuxe K., et al. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Journal of Neural Transmission 1988; 73: 191–203
   PubMed Web of Science ®Google Scholar
• Langer S.Z., Shoemaker H. Effects of antidepressants on monoamine transporters. Progress in Neuropsychopharmacology and Biological Psychiatry 1988; 12: 193
   Google Scholar
• Lapin I.P., Oxenkrug G.F. Intensification of central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1969; i: 132–136
   Google Scholar
• Lawrence K.M., De Paermentier F., Cheetha S.C., Crompton M.R., Katorna C.L., Horton R.W. Brain 5-HT uptake sites labelled with 3H-paroxetine in post-mortem samples from depressed suicide victims. British Journal of Pharmacology 1989; 98: 812
   Google Scholar
• Leonard B.E. The comparative pharmacology of new antidepressants. Journal of Clinical Psychiatry 1993; 54: 3–15, Suppl
   Google Scholar
• Leonard B.E. Second generation antidepressants: chemical diversity but unity of action?. Psychopharmacology of Depression, S.A. Montgomery, T.H. Corn. Oxford University Press, Oxford 1994a
   Google Scholar
• Leonard B.E. Serotonin receptors—where are they going?. International Clinical Psychopharmacology 1994b; 9(Suppl. 1)7–18
   Google Scholar
• Leysen J.E., Awontere F., Kennis L., et al. Receptor binding profile of R 414681, a novel antagonist at 5-HT2 receptors. Life Science 1981; 20: 1015–1018
   Google Scholar
• Linnoila M., Virkkunen M. Monoamines, glucose metabolism and impulse control. 5-hydroxytryptamine in Psychiatry—a spectrum of ideas, M. Sandler, A. Coppen, S. Harnetts. Oxford University Press, Oxford 1991
   Google Scholar
• McAdams C., Colohan F.J., Brophy J., Leonard B.E. Alteration by a plasma factor of platelet aggregation and 5-HT uptake in depression. Biological Psychiatry 1992; 32: 296
   Google Scholar
• McLean D.R., Nihei T. Uptake of dopamine and 5-hydroxytryptamine by platelets from patients with Huntington's chorea. Lancet 1977; 1: 249
   Google Scholar
• Marek G.J., Li A., Serden L.S. Selective 5-hydroxytryptamine 2 antagonists have antidepressant like effects on differential-reinforcement of low rate 72-s schedule. Journal of Pharmacological Experimental Therapy 1989; 250: 60–68
   Google Scholar
• Martin P., Soubrie P., Simon P. Shuttle-box deficits induced by inescapable shocks in rats: reversal by the beta-adrenoceptor stimulants clenbuterol and salbutamol. Pharmacology, Biochemistry and Behavior 1986; 24: 177–181
   Google Scholar
• Modai I., Apter A., Meltzer M., Tyano S., Walevski A., Jerushalm Z. Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric in-patients. Neuropsychobiology 1989; 21: 9
   Google Scholar
• Nelson D.R., Palmer K.J., Johnson A.M. Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatrica Scandinavia 1989; 80(Suppl. 350)21–23
   Google Scholar
• Nestler E.J., Walaas S.T., Greengard P. Neuronal phosphoproteins: physiological and clinical implications. Science 1984; 225: 1357–1364
   PubMed Web of Science ®Google Scholar
• Ogren S.O., Fuxe K. Effects of antidepressant drugs on cerebral serotonin receptors. Neuropharmacology of Serotonin, A.R. Green. Oxford University Press, Oxford 1985
   Google Scholar
• Oswald I., Brezinova V., Funleavy D.L. On the slowness of action of tricyclic antidepressants. British Journal of Psychiatry 1972; 120: 673–677
   PubMed Web of Science ®Google Scholar
• Paul S.M. Serotonin uptake sites in platelets and human brain: clinical implications. Proceedings of the Regional Symposium World Psychiatric Association. Copenhagen 1986, Abstract No. 293
   Google Scholar
• Paul S.M., Rehavi M., Skolnick P. Demonstration of specific “high affinity” binding sites for 3H-imipramine on human platelets. Life Science 1980; 26: 953
   PubMed Web of Science ®Google Scholar
• Paul S.M., Rehavi M., Skolnick P., Ballenger J.C., Goodwin F.K. Depressed patients have decreased binding of 3HT-imipramine to the platelet serotonin transporter. Archives of General Psychiatry 1981; 38: 1315
   PubMed Web of Science ®Google Scholar
• Pepin M.C., Beauluin S., Bardin N. Antidepressants regulate glucocorticoid receptor messenger RNA concentration in primary neuronal cultures. Molecular Brain Research 1989; 6: 77–83
   PubMedGoogle Scholar
• Peroutka S.J., Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 1980; 210: 88–90
   PubMed Web of Science ®Google Scholar
• Pinder R.M., Wieringa J.H. Third-generation antidepressants. Medical Research Reviews 1993; 13: 259–325
   PubMedGoogle Scholar
• Poirier M.F., Glazin A.M., Loo H., Pimoule C., Segonacxz A., Benkeflat C., Sechter D., Carifian E., Schoemaker H., Langer S.Z. Changes in 3H-5-HT uptake and 3H imipramine binding in platelets after clomipramine in healthy volunteers: Comparison with maprotiline and amitriptyline. Biological Psychiatry 1987; 22: 287
   Google Scholar
• Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 1978; 47: 379–85
   PubMed Web of Science ®Google Scholar
• Porsolt R.D., Chermat R., Siman P., Stern L. The tail suspension test: computerized device for evaluating psychotropic activity profile. Psychopharmacology 1986; 89: 528
   Google Scholar
• Porsolt R.D., Lenegre A., McArthur R.A. Pharmacological models of depression. Animal Models of Depression in Psychopharmacology, B. Olivier, J. Mos, T.L. Slangen. Birkhanser, Basel 1991
   Google Scholar
• Racagni G., Tinelu D., Bianchi E., . cAMP-dependent binding proteins and endogenous phosphorylation after anti-depressant treatment. 5-Hydroxytryptamine in Psychiatry, M. Sandler, A. Copper, S. Harnett, et al. Medical Publications, Oxford 1991; 116–123
   Google Scholar
• Raisman R., Sette M., Pinnoule C., Brilely M., Langer S.Z. High affinity 3H-desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline. European Journal of Pharmacology 1982; 78: 345–351
   PubMed Web of Science ®Google Scholar
• Rehavi M., Sokolovsky M. Multiple binding sites of tricyclic antidepressants to mammalian brain receptors. Brain Research 1978; 149: 525
   PubMed Web of Science ®Google Scholar
• Rehavi M., Skolnick P., Hulihan B., Paul S.M. High affinity binding of 3H-desipramine to rat cerebral cortex: Relationship to tricyclic antidepressant induced inhibition of noradrenaline uptake. European Journal of Pharmacology 1981; 70: 597
   PubMed Web of Science ®Google Scholar
• Rehavi M., Skolnick P., Brownstein M.J., Paul S.M. High affinity binding of 3H-desipramine to rat brain: A pre-synaptic marker for NA uptake sites. Journal of Neurochemistry 1982; 38: 899
   Google Scholar
• Rehavi M., Sepcuti H., Weizman A. Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain. Brain Research 1987; 410: 135
   PubMed Web of Science ®Google Scholar
• Richardson J.S. The olfactory bulbectomized rat as a model of major depressive disorder. Neuromethods Vol 19, Animal models in Psychiatry II, A. Boulton, G. Baker, M. Martin-Iverson. The Humana Press Inc, New Jersey 1991
   Google Scholar
• Richelson E. Antidepressants and brain neurochemistry. Mayo Clinic Proceedings 1990; 65: 1227–1236
   PubMed Web of Science ®Google Scholar
• Sanders-Bush E., Breeding M., Knoth K., et al. Sertraline-induced desensitization of the serotonin 5-HT2 receptors transmembrane signalling system. Psychopharmacology 1989; 99: 64–69
   PubMedGoogle Scholar
• Schildkraut J.J. The catecholamine hypothesis of affective disorders, a review of supporting evidence. American Journal of Psychiatry 1965; 122: 413–418
   Google Scholar
• Scheffel V., Hartig P.R. In vitro labelling of serotonin uptake sites with 3H-paroxetine. Journal of Neurochemistry 1989; 52: 1602–1605
   Google Scholar
• Seligman M.E.P. Helplessness. Freeman, San Francisco 1975
   Google Scholar
• Sheard M. The effect of p-chlorophenylamine on behaviour of rats: relation to brain serotonin and 5-hydroxyindoleacetic acid. Brain Research 1969; 15: 524–8
   PubMed Web of Science ®Google Scholar
• Sherman A.D., Sacquitne J.L., Petty F. Specificity of die learned helpless model of depression. Pharmacology, Biochemistry, & Behavior 1982; 16: 449–454
   PubMed Web of Science ®Google Scholar
• Stanley M., Mann J.J. Increased Serotonin 2 binding sites in frontal cortex of suicide victims. Lancet 1983; 1: 214–216
   PubMed Web of Science ®Google Scholar
• Stockmeier C.A., Keller K.J. In vivo regulation of the serotonin 2 receptor in rat brain. Life Science 1986; 38: 117–127
   PubMed Web of Science ®Google Scholar
• Stolz J.F., Marsden C.A., Middlemiss D.M. Effect of chronic antidepressant treatment and subsequent withdrawal on 3H-5-HT and 3H-spiperone binding in rat frontal cortex and serotonin mediated behaviour. Psychopharmacology 1983; 80: 150–155
   PubMed Web of Science ®Google Scholar
• Strobel G.H., Calixto J.B., Ballejo G. Decreased GABA modulatory effect on rat vas deferens neurotransmission after chronic administration of imipramine. Cell Molecular Neurobiology 1989; 9: 469
   Google Scholar
• Sulser F., Sanders-Bush E. The serotonin norepinephrine link hypothesis of affective disorders: receptor interactions in the brain. Molecular Basis of Neuronal Responsiveness, R.H. Erlich, E. Lennox, E. Kornecki, et al. Plenum, New York, NY 1987
   Google Scholar
• Suranyi-Cadotte B.E., Wood P.L., Nair N.P., Schwartz G. Normalization of platelet 3H-imipramine binding in depressed patients during revision. European Journal of Pharmacology 1982; 85: 357
   PubMed Web of Science ®Google Scholar
• Tang S.W., Cheung S., Strijewski A., Chudzik J., Helmeste D. Anti-imipramine antibodies recognize endogenous serotonin and imipramine binding inhibitors. Psychiatric Research 1990; 34: 205
   Google Scholar
• Tuomisto J., Tukiainen E. Decreased uptake of 5-hydroxytryptamine in blood platelet from depressed patients. Nature 1976; 262: 596
   PubMed Web of Science ®Google Scholar
• Van Riezen H., Leonard B.E. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats. Pharmacology and Therapeutics 1990; 47: 21–34
   PubMed Web of Science ®Google Scholar
• Vergnes M., Karli P. D'enclenchement du comportement, d'agression interspecifique. Rat et souris par ablation bilaterale des ulbes olfactifs. Comptes Rendus de Seances de la Sociéte de Biologie et de sesfiliales 1963; 157: 1061–3
   Google Scholar
• Vergnes M., Kempf E. Effects of hypothalamic injections of 5,7 dihydroxytryptamine on elicitation of mouse killing in rats. Behavioural Brain Research 1982; 5: 387–97
   Google Scholar
• Wennogle L.P., Meyerson L.R. Serotonin uptake inhibitors differently modulate high affinity imipramine dissociation in human platelet membranes. Life Science 1985; 36: 1541
   Google Scholar
• Willner P. Depression: a Psychological Synthesis. John Wiley, & Sons, New York 1985
   Google Scholar
• Willner P. Animal models of Depression. Handbook of Depression and Anxiety—a biological approach, J.A. den Boer, J.M.A. Sitsen. Marcel Dekker Inc., New York 1994
   Google Scholar
• Wong K.L., Bruck R.C., Farabman I.A. Amitriptyline mediated inhibition of neurite outgrowth from chick embryonic cerebral explants involves a reduction in adenylate cyclase activity. Journal of Neurochemistry 1991; 57: 1223–1330
   Google Scholar